Del Taco Restaurants Inc
Total Consideration
$7.2M
JACK IN THE BOX INC. — Key Metrics
3 years of history · ending 2025-09-28 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Per Share Metrics
Expense Ratios
Working Capital Analysis
Valuation Multiples
Cash-Flow Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
Liquidity & Leverage Ratios
Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)
EPS (Diluted)
$-4
Book Value Per Share
$-49
Free Cash Flow Per Share
$4
Cash Per Share
—
Revenue Per Share
$77
OCF Per Share
$9
Return on Equity
9.0%
Return on Assets
-3.0%
Return on Invested Capital
1.6%
Debt to Equity
—
Current Ratio
0.51
Quick Ratio
0.51
Asset Turnover
0.55
Days Payables Outstanding
—
Days Inventory On Hand
—
SBC / Revenue
0.6%
Capex / Revenue
6.0%
Working Capital
$-210M
Net Current Asset Value
$220M
Invested Capital
$-938M
OCF / Net Income
-2.01
FCF / Net Income
-0.92
Accruals Ratio (Sloan)
-9.4%
Net Debt
—
Net Debt / EBITDA
—
Dividend Coverage
9.77
Capex Coverage
1.84
Tangible Common Equity
$-1.08B
TCE / Total Assets
-41.8%
Goodwill / Total Assets
5.2%
NOPAT
$-14M
Cash ROIC
-8.3%
WC / Revenue
-14.3%
Capex / D&A
1.51
Reinvestment Rate
-205.3%
Total Payout Ratio
-26.8%
Asset Growth vs Revenue Growth
1.5%
Revenue 5Y CAGR
7.5%
EPS 5Y CAGR
1.5%
FCF 5Y CAGR
-9.8%
EBITDA 5Y CAGR
-32.3%
Book Value 5Y CAGR
—
Stock Price (FY-end)
$20
Market Cap
$385M
P/E Ratio
10.41
P/S Ratio
0.26
P/B Ratio
—
P/TB Ratio
—
P/OCF Ratio
2.37
P/FCF Ratio
5.20
Enterprise Value
$385M
EV / EBITDA
9.58
EV / Sales
0.26
EV / FCF
5.20
FCF Yield
19.2%
Dividend Yield
4.3%
Shareholder Yield
3.5%
Buyback Yield
1.3%
Capex Yield
22.9%
Dividend Per Share
$1
DPS YoY Growth
-49.8%
Operating Leverage
9.84
Graham Number
—
Shares Variation (YoY)
-2.6%
Beta (5Y)
0.88
Cost of Equity
8.9%
52W High
$50
52W Low
$17
Trailing Return 1Y
-54.7%
Trailing Return 5Y
-72.5%
F-Score (Piotroski)
4.00
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.
EPS — Consensus vs Actual
Revenue — Consensus vs Actual
Stock Price on Earnings Dates
JACK IN THE BOX INC. — Effective Tax Rate ReconciliationNEW
Bridges from the federal statutory rate (21% post-TCJA) to the effective tax rate via the issuer's tax-note reconciliation lines. Sourced from EffectiveIncomeTaxRateReconciliation* flat CompanyFacts concepts. Conditional lines (R&D credits, FDII, SBC, valuation allowance, etc.) only render when the issuer discloses them. Persistent divergence between accrual tax expense and cash taxes paid is a leading signal for deferred-tax buildup.
Effective Rate Trend
| Reconciliation Line | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Federal Statutory Rate | 21.00% | 21.00% | 21.00% | 21.00% | 21.00% | 21.00% |
| State & Local Income Taxes | 5.30% | 5.10% | 5.20% | 5.60% | 5.40% | 5.30% |
| Foreign Rate Differential | — | — | — | — | — | — |
| Other Adjustments | -0.40% | -0.50% | 0.10% | 0.00% | -1.20% | -1.50% |
| Nondeductible Expenses | 0.00% | 0.00% | 0.60% | 0.00% | — | — |
| Tax Law Change | 0.00% | — | — | — | — | — |
| Effective Tax Rate | 26.80% | 25.20% | 28.50% | 30.90% | -7.49% | 21.50% |
Cash vs Accrual
| Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Income Tax Expense (Accrual) | $32.7M | $55.9M | $46.1M | $58.5M | $32.4M | −$22.1M |
| Income Taxes Paid (Cash) | — | — | — | — | — | — |
JACK IN THE BOX INC. — M&A AcquisitionsNEW
Per-deal acquisition disclosures sourced from us-gaap:BusinessAcquisitionAxis dimensional XBRL. Each card surfaces the deal's purchase-price allocation (goodwill vs intangibles vs liabilities), contingent consideration (unpaid earn-outs), and pro-forma combined-entity numbers. Probability-of-Success (PoS) factor on biotech targets is the ASC 805 contingent-consideration valuation — higher = closer to commercialization, higher implied target value.